Literature DB >> 9816148

Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability.

P C Lim1, D Tester, W Cliby, S C Ziesmer, P C Roche, L Hartmann, S N Thibodeau, K C Podratz, R B Jenkins.   

Abstract

DNA mismatch repair genes have been reported to play a role in the pathogenesis of hereditary nonpolyposis colorectal cancer (HNPCC). Mutations of DNA mismatch repair genes have accounted for 90% of HNPCC-related colon and endometrial tumors. These mutations have been associated with microsatellite instability (MIN). Because endometrial cancer (EC) is the most common extracolonic malignancy associated with HNPCC, we hypothesized that similar molecular alterations may occur in sporadic endometrial tumors exhibiting MIN. Mutational analysis of the MSH2 and MLH1 genes was undertaken in sporadic EC that demonstrate MIN to determine the role of these genes in the pathogenesis of sporadic ECs. Established microsatellite markers were used to determine the incidence of MIN from 28 patients with sporadic EC. MIN was observed in 32% (9 of 28) of the tumor specimens analyzed. Mutational analysis of MSH2 and MLH1 genes was performed by immunohistochemical analysis and direct sequencing of tumor specimens that exhibited MIN. All 28 tumor specimens exhibited strong nuclear staining with both MSH2 and MLH1 antibodies, suggesting the absence of mutations. Sequencing of all exons of both the MSH2 and MLH1 genes in the nine MIN-positive tumor specimens demonstrated no mutations. We conclude that the MSH2 and MLH1 genes do not play a role in the pathogenesis of sporadic endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816148

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  7 in total

1.  hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?

Authors:  L H Ellenson
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

Review 3.  DNA methylation in endometrial cancer.

Authors:  Meng Hua Tao; Jo L Freudenheim
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

4.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

Authors:  M Esteller; L Catasus; X Matias-Guiu; G L Mutter; J Prat; S B Baylin; J G Herman
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Increased hMSH2 protein expression in glioblastoma multiforme.

Authors:  Tapasya Srivastava; Parthaprasad Chattopadhyay; A K Mahapatra; Chitra Sarkar; Subrata Sinha
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

6.  The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.

Authors:  N A J Ryan; M A Glaire; D Blake; M Cabrera-Dandy; D G Evans; E J Crosbie
Journal:  Genet Med       Date:  2019-05-14       Impact factor: 8.822

7.  Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.

Authors:  H S Kassem; J M Varley; S M Hamam; G P Margison
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.